Quest Diagnostics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.About DGX
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments.
DGX Key Statistics
Stock Snapshot
With a market cap of 27.71B, Quest Diagnostics(DGX) trades at $251.90. The stock has a price-to-earnings ratio of 24.45 and currently yields dividends of 1.35%.
On 2026-10-29, Quest Diagnostics(DGX) stock moved within a range of $245.96 to $252.12. With shares now at $251.90, the stock is trading +2.4% above its intraday low and -0.1% below the session's peak.
Trading activity shows a volume of 532.77K, compared to an average daily volume of 1.04M.
The stock's 52-week range extends from a low of $171.18 to a high of $252.12.
The stock's 52-week range extends from a low of $171.18 to a high of $252.12.
DGX News
...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different wa...
Quest Diagnostics raised its 2026 net revenue outlook to US$12.065b to US$12.105b and lifted reported diluted EPS guidance to US$10.21 to US$10.31 after reporti...
Analyst ratings
55%
of 20 ratingsMore DGX News
Waters (WAT) just put cervical cancer screening at the center of its story by signing new partnerships with Labcorp and Quest Diagnostics to widen access to the...
Quest Diagnostics ((DGX)) has held its Q3 earnings call. Read on for the main highlights of the call. Quest Diagnostics’ latest earnings call struck a notably u...
Medical lab testing giant Quest Diagnostics has confirmed a cyberattack and data breach affecting an as-yet unspecified amount of sensitive patient information...
Baird analyst Eric Coldwell raised the firm’s price target on Quest Diagnostics (DGX) to $262 from $260 and keeps a Neutral rating on the shares. The firm updat...
Quest Diagnostics walked into its Q3 2026 report with a reputation as a steady cash generator in diagnostics and a stock that had already delivered mid‑single d...
Quest Diagnostics (DGX) is back in focus after reporting third quarter results that showed higher sales and net income year over year, raising full year guidanc...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.